Reduced Mortality and Severe Disability Rates in the SENTIS Trial
- Schellinger, P.D.
- Shuaib, A.
- Köhrmann, M.
- Liebeskind, D.S.
- Jovin, T.
- Hammer, M.D.
- Sen, S.
- Huang, D.Y.
- Solander, S.
- Gupta, R.
- Leker, R.R.
- Saver, J.L.
Publication date
January 2013
DOIAbstract
The Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial showed a trend for reduced all-cause mortality and positive secondary safety end point outcomes. We present further analyses of the mortality and severe disability data from the Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial
Add to ORKG